Karine Lacombe to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Karine Lacombe has written about Randomized Controlled Trials as Topic.
Connection Strength
0.039
-
Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial. Trials. 2021 Mar 09; 22(1):199.
Score: 0.014
-
[COVID-19: Still a place for tocilizumab?] Rev Med Interne. 2021 02; 42(2):73-78.
Score: 0.014
-
Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. Clin Infect Dis. 2018 01 06; 66(1):112-120.
Score: 0.011